Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2010

View Archived Issues

Dengue virus therapy AVI-6006 shows promise in animal models

Intranasal GI.1 norovirus virus-like particle vaccine is safe and efficacious in healthy volunteers

Quadrivalent Fluzone QIV is as safe and immunogenic as trivalent flu vaccines

AN-3661 is efficacious against Plasmodium infections in mice

Marina Biotech receives approval for CEQ-508 trial in familial adenomatous polyposis

Advanced Life Sciences enters into CRADA to advance Restanza for malaria

Bayer Schering Pharma claims new neutrophil elastase inhibitors

Bristol-Myers Squibb and Simcere to jointly develop BMS-817378

FDA approves Cymbalta for management of chronic musculoskeletal pain

New cytotoxic agents described for colon cancer therapy

Provectus plans course of action for approval of PV-10 in Australia

Advaxis and NCI enter into CRADA to develop Listeria vaccines

Shire provides update on progress of third quarter 2010

Italian scientists present new inhibitors of HCV NS5B

Phase III data reported on crofelemer for diarrhea in HIV-infected persons on antiretroviral therapy

Sanofi-aventis presents new inhibitors of PDE7 and/or PDE8

Boehringer Ingelheim identifies new reverse transcriptase inhibitors

Alnylam grants property license to Tekmira for TKM-Ebola

Nicotine vaccine NIC-002 enters phase II study

FDA approves once-daily Kombiglyze XR tablets for type 2 diabetes

FDA clears Vitros intact parathyroid hormone assay

Primary endpoint met in phase IIa vidofludimus trial in inflammatory bowel disease

Kuros regains rights to KUR-112, KUR-212 and KUR-213

Phase IIb data reported on LIPO-102 for selective nonablative fat reduction

BMK.1 inhibitor XMD-8-92 inhibits tumor growth in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...